An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03964168

Enrollment

Registered

2019-05-28

Start date

2019-07-31

Completion date

2020-03-03

Last updated

2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Brief summary

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Detailed description

Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.

Interventions

DRUGBiologic Agent

Patients who discontinued a bioloic agent

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Male or female adults ≥ 18 years of age. * Was receiving first or second biologic therapy * Has not had a follow up with treating physician in ≥ 9 months

Exclusion criteria

* Actively receiving biologic therapy * Was not receiving first or second biologic therapy

Design outcomes

Primary

Measure	Time frame	Description
Determine the most common reason for discontinuation	5 years	Tally number of patients who discontinued due to adverse events, insurance issues or category other.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026